Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jade Biosciences, Inc. - Common Stock (NQ:JBIO)

7.700 -0.060 (-0.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jade Biosciences, Inc. - Common Stock

Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy
From Jade Biosciences
Via GlobeNewswire
Jade Biosciences to Participate in Upcoming Conferences
From Jade Biosciences
Via GlobeNewswire
Jade Biosciences Posts Wider Loss in Q2
Via The Motley Fool
Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From Jade Biosciences
Via GlobeNewswire
Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Why Sarepta Therapeutics Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Jade Biosciences to Participate in Two Upcoming Investor Conferences
From Jade Biosciences
Via GlobeNewswire
Jade Biosciences Appoints Brad Dahms as Chief Financial Officer
From Jade Biosciences
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy
From Jade Biosciences
Via GlobeNewswire
Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress
Company to host conference call and webcast on June 9, 2025, at 8:00 a.m. ET 
From Jade Biosciences
Via GlobeNewswire
Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update
From Jade Biosciences
Via GlobeNewswire
Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference
From Jade Biosciences
Via GlobeNewswire
Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.